Results 51 to 60 of about 17,280 (228)

The role of peptides in bone healing and regeneration: A systematic review [PDF]

, 2016
Background: Bone tissue engineering and the research surrounding peptides has expanded significantly over the last few decades. Several peptides have been shown to support and stimulate the bone healing response and have been proposed as therapeutic ...
A Au, A Bitschnau, A Horii, A Kasaj, A Kubler, A Memeo, A Mesfin, A Mota, A Oteo-Alvaro, A Rezania, A Rezania, A Saito, A Scarano, A Shekaran, A Spreafico, A Verheyen, A Vignery, AA Sawyer, AC Karaplis, AM Wojtowicz, Anastasios Lampropoulos, AR El-Ghannam, AU Dignass, B Elmengaard, B Elmengaard, B Mognetti, B Olszewska-Pazdrak, BH Vickery, BK Culpepper, BK Culpepper, BM Hanratty, BP Sherman, C Trasatti, CC Wu, CD Reyes, CD Reyes, CG Trejo, CT Yu, D Moher, D Paridis, DJ Hak, DM Ferris, E Garreta, E Jimi, E Mrak, E Peggion, E Ruoslahti, E Smith, EA Cavalcanti-Adam, ED Karagiannis, EF Morgan, EL Hedberg, Elena Jones, EM Lindley, EP Barboza, F Butz, F Fukuda, F Gelain, F Gomar, FA Suaid, G An, G Balasundaram, G Balasundaram, G Cakmak, G Li, G Li, G Tian, G Xu, G Zimmermann, Giorgio Maria Calori, GM Calori, GN Onuoha, H Ceylan, H Drissi, H Drissi, H Egusa, H Emam, H Huang, H Misawa, H Nakahara, H Nguyen, H Shin, H Tachiiri, H Wang, HH Rowshan, I Bab, I Bab, I El-Madany, I Millet, I Pountos, I Pountos, I Pountos, I Pountos, I Pountos, I Villa, IJ Ezquerro, Ippokratis Pountos, J Guan, J Guo, J Holm, J Jo, J Jo, J Li, J Strnad, JA Guimaraes, JA Lee, JC Chang, JD Bashutski, JD Smucker, JE Madsen, JF Whitfield, JM Anderson, JM Latzman, JS Suh, JT Ryaby, JW Calland, JW Park, JY Lee, JY Lee, JY Lee, JY Lee, JY Lee, K Nozaka, K Ochi, K Sarahrudi, K Tamai, KC Dee, KC Dee, KD Hankenson, KL Ong, KM Hennessy, KM Hennessy, KM Park, L Kruger, L Pietrogrande, L Wang, L Zhang, LB Priddy, LF Castro de, LR Amir, M Amling, M Degidi, M Deng, M Gelbart, M Gilbert, M Giorgio Calori, M Ikeno, M Kantlehner, M Komrakova, M Nelson, M Ozeki, M Panteli, M Roberto-Rodrigues, M Ronga, M Schuler, M Shuqiang, M Thorwarth, M Thorwarth, MA Brager, MB Murphy, MC Durrieu, MC Simmonds, ME Cupp, Michalis Panteli, MK Shin, ML Bhongade, MM Martino, MP Bostrom, MP Bostrom, MR Sheller, N Fukushima, N Gabarin, N Mardas, N Tomomatsu, O Ashman, P Aspenberg, P Aspenberg, P Du, P Philippart, Peter V. Giannoudis, PT Rubery, PV Giannoudis, Q Fei, Q Liu, Q Zhao, R Ballica, R Visser, R Yoshimi, R Yukna, R Zura, RA Stile, RA Yukna, RA Yukna, RA Yukna, RE Dent-Acosta, RE Jung, RN Palchesko, RR Barros, RS Bhatnagar, S Cakarer, S Chintamaneni, S Dai, S Hofmann, S Komatsubara, S Matos, S Rammelt, S Schutzenberger, S Sun, S Vastardis, S Zhang, S Zheng, SG Amara, SH Park, SJ Gomberg, SJ Sample, SP Massia, SY Yoo, T Fujita, T Goff, T Hanks, T Hayashibara, T Hou, T Manabe, T Schinke, T Vordemvenne, TD Sargeant, TJ Martin, W Li, W Schneiders, W Thein-Han, X Li, XB Yang, Y Furuya, Y Gabet, Y Hamada, Y Hamada, Y Song, Y Wang, YH Wang, YJ Kim, YJ Kim, YM Alkhiary, YQ Sun, Z Artzi, Z Artzi, Z Chen, Z Dahabreh, Z Greenberg, Z Li, ZX Chen, ZY Zhao   +250 more
core   +2 more sources

Clinical Practice Patterns in Bone Health Assessment and Management in Endogenous Cushing's Syndrome

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Skeletal fragility is a common complication of endogenous Cushing's Syndrome (CS), although specific guidelines for managing bone health are lacking. This study aimed to assess clinicians' current engagement with bone health assessment and management in patients with endogenous CS. Design Retrospective‐cohort design. Patients Seventy‐
Preeshila Behary, Dinushan Raveendran, Ramesh Nair, Aimee Di Marco, Debbie Papadopoulou, Florian Wernig, Ali Abbara, Karim Meeran, Niamh Martin, Jeremy Cox, Alexander N. Comninos   +10 more
wiley   +1 more source

Effect of Teriparatide on Bone Mineral Density and Trabecular Bone Score in Type 2 Diabetic Patients with Osteoporosis: A Retrospective Cohort Study

Medicina, 2022
The BMDs of the lumbar spine, whole femur, and femoral neck and TBS were measured. Change in BMD or TBS was defined as the BMD or TBS at follow-up, performed 1 year after baseline, minus baseline BMD or TBS.
Chihiro Munekawa, Yoshitaka Hashimoto, Noriyuki Kitagawa, Takafumi Osaka, Masahide Hamaguchi, Michiaki Fukui   +5 more
doaj   +1 more source

Treatment Trade‐Offs and Choices for Femoral Fractures: A Systematic Review and Meta‐Analysis

Orthopaedic Surgery, Volume 17, Issue 5, Page 1298-1313, May 2025.
This review examines the trade‐offs between surgical intervention and traction therapy for adult and elderly patients with femoral fractures and surgical contraindications, particularly in resource‐limited settings. While intramedullary nailing may offer better clinical outcomes, traction therapy is often preferred due to limited surgical resources ...
Jiarui Li, Zhu Guo, Tianrui Wang, Kunyue Xing, Wenzhuo Wang, Yaowei Liu, Jiyao Xing, Hongfei Xiang, Jingdong Wang, Bohua Chen, Dongming Xing, Xiaolin Wu   +11 more
wiley   +1 more source

Acute development of cortical porosity and endosteal naïve bone formation from the daily but not weekly short-term administration of PTH in rabbit. [PDF]

PLoS ONE, 2017
Teriparatide [human parathyroid hormone (1-34)], which exerts an anabolic effect on bone, is used for the treatment of osteoporosis in patients who are at a high risk for fracture.
Hiroshi Yamane, Aya Takakura, Yukari Shimadzu, Toshiyuki Kodama, Ji-Won Lee, Yukihiro Isogai, Toshinori Ishizuya, Ryoko Takao-Kawabata, Tadahiro Iimura   +8 more
doaj   +1 more source

Molecular pathophysiology of chronic kidney disease–mineral and bone disorder: Focus on the fibroblast growth factor 23–Klotho axis and bone turnover dynamics

Experimental Physiology, EarlyView.
Abstract Chronic kidney disease–mineral and bone disorder (CKD‐MBD) is a major complication of chronic kidney disease (CKD), characterized by disruptions in mineral metabolism, abnormal bone turnover and vascular calcification, which collectively increase the risk of fractures and cardiovascular disease.
Alief Waitupu, Laras Pratiwi, Henry Sutanto, Djoko Santoso, Decsa Medika Hertanto   +4 more
wiley   +1 more source

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy : a randomised, open-label, phase 3 trial [PDF]

, 2017
Background: Previous bisphosphonate treatment attenuates the bone-forming effect of teriparatide. We compared the effects of 12 months of romosozumab (AMG 785), a sclerostin monoclonal antibody, versus teriparatide on bone mineral density (BMD) in women ...
Bolognese, Michael A, Brown, Jacques P, Crittenden, Daria B, Daizadeh, Nadia S, Dokoupilova, Eva, Engelke, Klaus, Fernando Molina, Jose, Finkelstein, Joel S, Genant, Harry K, Goemaere, Stefan, Grauer, Andreas, Hyldstrup, Lars, Jodar-Gimeno, Esteban, Keaveny, Tony M, Kendler, David, Lakatos, Peter, Langdahl, Bente L, Libanati, Cesar, Maddox, Judy, Malouf, Jorge, Massari, Fabio E, Rosa Ulla, Maria   +21 more
core   +2 more sources

Contrast‐Enhanced Ultrasound (CEUS) Reveals Perfusion of Human Bone in Acute Fracture Healing: A Pilot Study

Journal of Orthopaedic Research, Volume 44, Issue 1, January 2026.
ABSTRACT Bone fractures are common injuries with reported non‐union rates of up to 9%. Current treatments for non‐union include surgery with complication rates of up to 17% and significant costs. Microbubbles are used clinically in ultrasonography as contrast agents and have been shown to deliver therapeutics to desired locations by noninvasive ...
D. Cadoux‐Hudson, M. Thomas, J. Hurst, R. Schranz, A. Gerrish, K. Wallace, D. Warwick, D. Carugo, E. Stride, S. Tilley, N. D. Evans   +10 more
wiley   +1 more source

Effects of Teriparatide on Bone Mineral Density and Prevention of Fragility Fractures in Saudi Arabian Subjects with Osteoporosis: A Two‐Year Clinical Study from a Single Center [PDF]

, 2022
Mir Sadat‐Ali, Abdallah S. Al-Omran, Khalid AlTabash, Dakheel A Al-Dakheel, Salma Elansassy, Tarek M. Hegazi, Mona Al Muhaish   +6 more
openalex   +1 more source

Dysfunctional stem and progenitor cells impair fracture healing with age [PDF]

, 2019
Successful fracture healing requires the simultaneous regeneration of both the bone and vasculature; mesenchymal stem cells (MSCs) are directed to replace the bone tissue, while endothelial progenitor cells (EPCs) form the new vasculature that supplies ...
Clauss, Matthias, Fennimore, Alanna, Gunderson, Zachary J., Kacena, Melissa A., Karnik, Sonali, Li, Jiliang, Loghmani, M. Terry, Low, Philip S., Lowery, Jonathan W., McKinley, Todd O., Nielsen, Jeffery J., Promer, Hunter J., Wagner, Diane R.   +12 more
core   +1 more source